{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:50:32Z","timestamp":1787165432684,"version":"build-2736575974"},"reference-count":41,"publisher":"BMJ","issue":"7","license":[{"start":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T00:00:00Z","timestamp":1753833600000},"content-version":"unspecified","delay-in-days":29,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Health Education England","award":["NIHR300542"],"award-info":[{"award-number":["NIHR300542"]}]},{"DOI":"10.13039\/501100000272","name":"National Institute of Health Research","doi-asserted-by":"crossref","award":["NIHR300542"],"award-info":[{"award-number":["NIHR300542"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2025,6,30]]},"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To develop a behavioural intervention package to support non-allergist healthcare workers (HCWs) to remove incorrect penA records from medical and surgical adult inpatients. This paper describes the development of the penicillin allergy de-labelling (PADL) intervention and the implementation intervention that will support non-allergist-delivered PADL.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>We combined evidence-based, theory-based and person-based approaches. Qualitative research with healthcare professionals and patients explored barriers and enablers to implementation of the proposed PADL pathway. Key intervention design objectives and the key features of the implementation intervention required to achieve each objective were then developed and captured as guiding principles. We produced a logic model, integrating the theoretical domains framework to identify the behavioural influences on PADL and the behaviour change wheel to show how the implementation intervention is hypothesised to address the target behaviours. The implementation intervention package was then reviewed by stakeholders and topic experts for further refinement and optimisation. Finally, we outline how the implementation intervention will be evaluated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting<\/jats:title>\n                    <jats:p>Single-centre District General Hospital in the SW England servicing a rural community of 575\u2009000 people without local allergy services.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>HCWs reported PADL needed to be structured, standardised, evidence based and supported by hospital approved guidelines with easy to access patient information leaflets, supported by a sustained programme of education and training with named PADL leaders and visible PADL champions. Patients wanted a good explanation of the benefits and risks of testing and the benefits of having their \u2018penA\u2019 record removed. The identified HCW target behaviours were: taking a penA allergy focused history and to risk assess the patient\u2019s penA history; to then either de-label the patient on history alone (direct de-label; DDL) or prescribe a direct oral challenge (DOC) dose; to perform baseline and post-test observations and counsel the patient on the risks of penA records and on the risks and the benefits of PADL. We identified barriers to target behaviours that we considered both important and modifiable, which included: lack of confidence in taking a penA focused history, PADL not viewed as a priority, low confidence with differentiating low-risk and high-risk penA histories, concerns about the safety of DOC, a requirement for senior support for nurses to deliver the observations and senior support for the other HCWs to deliver PADL, access to an expert for advice when required, a lack of PADL champions to promote PADL, and PADL not being supported by the organisation. The identified patient target behaviours were acceptance of the opportunity to be de-labelled via either DDL or DOC and willingness to take penicillin when prescribed. We developed intervention components to target the HCW and patient target behaviours which included: Education, expert advice made available from Infection specialists, a named PADL champion, hospital endorsed PADL guideline with necessary tools to enable PADL and patient information leaflets. The implementation intervention was further optimised through workshops with PADL researchers and stakeholders. The Consolidated Framework for Implementation Research outcome addendum was used to define both implementation intervention and PADL intervention outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>We have developed a theory-based and stakeholder-developed implementation intervention to support inpatient PADL delivered by a multiprofession workforce. The intervention will be tested in a single hospital and scalability explored.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2024-096452","type":"journal-article","created":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T11:20:27Z","timestamp":1753874427000},"page":"e096452","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":7,"title":["Description of the combined evidence-based, theory-based and person-based approaches used to develop a behavioural intervention package to support non-allergist healthcare workers to remove incorrect penicillin allergy records from medical and surgical adult inpatients in a UK hospital"],"prefix":"10.1136","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6113-9810","authenticated-orcid":false,"given":"Neil","family":"Powell","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Royal Cornwall Hospital, Truro, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathew","family":"Upton","sequence":"additional","affiliation":[{"name":"University of Plymouth, Plymouth, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bridie","family":"Kent","sequence":"additional","affiliation":[{"name":"Nursing and Midwifery, Plymouth University, Plymouth, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Sandoe","sequence":"additional","affiliation":[{"name":"Department of Microbiology, University of Leeds Faculty of Medicine and Health, Leeds, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4470-1151","authenticated-orcid":false,"given":"Sarah","family":"Tonkin-Crine","sequence":"additional","affiliation":[{"name":"Nuffield Department of Primary Care Health Science, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,7,30]]},"reference":[{"key":"2025101811404575000_15.7.e096452.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2019.09.017"},{"key":"2025101811404575000_15.7.e096452.2","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jhin.2020.06.016","article-title":"Point prevalence of penicillin allergy in hospital inpatients","volume":"106","author":"Baxter","year":"2020","journal-title":"J Hosp Infect"},{"key":"2025101811404575000_15.7.e096452.3","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jhin.2020.05.042","article-title":"Impact of penicillin allergy records on antibiotic costs and length of hospital stay: a single-centre observational retrospective cohort","volume":"106","author":"Powell","year":"2020","journal-title":"J Hosp Infect"},{"key":"2025101811404575000_15.7.e096452.4","doi-asserted-by":"publisher","DOI":"10.1017\/ice.2020.1229"},{"key":"2025101811404575000_15.7.e096452.5","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jhin.2021.04.011","article-title":"The impact of penicillin allergy de-labelling on the WHO AWaRe antibiotic categories: a retrospective cohort study","volume":"115","author":"Powell","year":"2021","journal-title":"J Hosp Infect"},{"key":"2025101811404575000_15.7.e096452.6","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/j.cmi.2022.03.014","article-title":"Exposure to World Health Organization\u2019s AWaRe antibiotics and isolation of multidrug resistant bacteria: a systematic review and meta-analysis","volume":"28","author":"Sulis","year":"2022","journal-title":"Clin Microbiol Infect"},{"key":"2025101811404575000_15.7.e096452.7","unstructured":"Department of Health and Social Care TSG, Welsh Government, Department for Environment, Food & Rural Affairs, Department of Health (Northern Ireland), and Department of Agriculture, Environment and Rural Affairs (Northern Ireland) . Confronting antimicrobial resistance 2024 to 2029, 2024. Available: https:\/\/assets.publishing.service.gov.uk\/media\/663b9c451c82a7597d4f32fe\/Confronting-antimicrobial-resistance-2024-to-2029.pdf"},{"key":"2025101811404575000_15.7.e096452.8","unstructured":"Europe WROf . Antimicrobial stewardship interventions: a practical guide, 2021. Available: https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/340709\/9789289054980-eng.pdf"},{"key":"2025101811404575000_15.7.e096452.9","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)32218-9"},{"key":"2025101811404575000_15.7.e096452.10","doi-asserted-by":"publisher","DOI":"10.1111\/cea.12468"},{"key":"2025101811404575000_15.7.e096452.11","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S1081-1206(10)60402-4","article-title":"Skin testing and oral penicillin challenge in patients with a history of remote penicillin allergy","volume":"100","author":"Goldberg","year":"2008","journal-title":"Ann Allergy Asthma Immunol"},{"key":"2025101811404575000_15.7.e096452.12","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.ijid.2022.11.026","article-title":"The effectiveness of interventions that support penicillin allergy assessment and delabeling of adult and pediatric patients by nonallergy specialists: a systematic review and meta-analysis","volume":"129","author":"Powell","year":"2023","journal-title":"Int J Infect Dis"},{"key":"2025101811404575000_15.7.e096452.13","unstructured":"(PACE) BPACEG . Beta-Lactam Allergy Delabeling Guideline and Toolkit, 2021. Available: http:\/\/www.bccdc.ca\/Documents\/PACE%20Beta-lactam%20Allergy%20Delabeling%20Toolkit.pdf"},{"key":"2025101811404575000_15.7.e096452.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2022.08.028"},{"key":"2025101811404575000_15.7.e096452.15","doi-asserted-by":"crossref","first-page":"142","DOI":"10.5415\/apallergy.0000000000000122","article-title":"APAAACI clinical pathway on direct provocation testing for penicillin allergy delabeling","volume":"13","author":"Li","year":"2023","journal-title":"Asia Pac Allergy"},{"key":"2025101811404575000_15.7.e096452.16","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1111\/cea.14217","article-title":"BSACI guideline for the set\u2010up of penicillin allergy de\u2010labelling services by non\u2010allergists working in a hospital setting","volume":"52","author":"Savic","year":"2022","journal-title":"Clin Experimental Allergy"},{"key":"2025101811404575000_15.7.e096452.17","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2018.19283"},{"key":"2025101811404575000_15.7.e096452.18","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1111\/cea.13878","article-title":"An algorithm for safe de-labelling of antibiotic allergy in adult hospital in-patients","volume":"51","author":"Sneddon","year":"2021","journal-title":"Clin Exp Allergy"},{"key":"2025101811404575000_15.7.e096452.19","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.n2061","article-title":"A new framework for developing and evaluating complex interventions: update of Medical Research Council guidance","volume":"374","author":"Skivington","year":"2021","journal-title":"BMJ"},{"key":"2025101811404575000_15.7.e096452.20","doi-asserted-by":"crossref","DOI":"10.1186\/s12913-016-1958-5","article-title":"Clinical interventions, implementation interventions, and the potential greyness in between -a discussion paper","volume":"17","author":"Eldh","year":"2017","journal-title":"BMC Health Serv Res"},{"key":"2025101811404575000_15.7.e096452.21","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-029954","article-title":"Guidance on how to develop complex interventions to improve health and healthcare","volume":"9","author":"O\"Cathain","year":"2019","journal-title":"BMJ Open"},{"key":"2025101811404575000_15.7.e096452.22","doi-asserted-by":"crossref","DOI":"10.2196\/jmir.4055","article-title":"The person-based approach to intervention development: application to digital health-related behavior change interventions","volume":"17","author":"Yardley","year":"2015","journal-title":"J Med Internet Res"},{"key":"2025101811404575000_15.7.e096452.23","doi-asserted-by":"crossref","first-page":"3362","DOI":"10.1093\/jac\/dkz333","article-title":"Intervention planning for Antibiotic Review Kit (ARK): a digital and behavioural intervention to safely review and reduce antibiotic prescriptions in acute and general medicine","volume":"74","author":"Santillo","year":"2019","journal-title":"J Antimicrob Chemother"},{"key":"2025101811404575000_15.7.e096452.24","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-035793","article-title":"Developing a behavioural intervention package to identify and amend incorrect penicillin allergy records in UK general practice and subsequently change antibiotic use","volume":"10","author":"Santillo","year":"2020","journal-title":"BMJ Open"},{"key":"2025101811404575000_15.7.e096452.25","doi-asserted-by":"crossref","DOI":"10.1186\/s43058-021-00209-7","article-title":"Development of an intervention to support the implementation of evidence-based strategies for optimising antibiotic prescribing in general practice","volume":"2","author":"Borek","year":"2021","journal-title":"Implement Sci Commun"},{"key":"2025101811404575000_15.7.e096452.26","doi-asserted-by":"crossref","DOI":"10.1186\/s13012-017-0605-9","article-title":"A guide to using the Theoretical Domains Framework of behaviour change to investigate implementation problems","volume":"12","author":"Atkins","year":"2017","journal-title":"Implement Sci"},{"key":"2025101811404575000_15.7.e096452.27","doi-asserted-by":"publisher","DOI":"10.1186\/1748-5908-6-42"},{"key":"2025101811404575000_15.7.e096452.28","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-033516","article-title":"Guidance for reporting intervention development studies in health research (GUIDED): an evidence-based consensus study","volume":"10","author":"Duncan","year":"2020","journal-title":"BMJ Open"},{"key":"2025101811404575000_15.7.e096452.29","doi-asserted-by":"crossref","DOI":"10.1093\/jacamr\/dlad134","article-title":"Penicillin allergy de-labelling by non-allergists: a comparison of testing protocols","volume":"5","author":"Powell","year":"2023","journal-title":"JAC Antimicrob Resist"},{"key":"2025101811404575000_15.7.e096452.30","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmi.2023.06.024","article-title":"Removal of incorrect penicillin allergy labels in a UK hospital","volume":"29","author":"Hearsey","year":"2023","journal-title":"Clin Microbiol Infect"},{"key":"2025101811404575000_15.7.e096452.31","doi-asserted-by":"crossref","DOI":"10.1093\/jacamr\/dlae014","article-title":"Non-allergist healthcare workers views on delivering a penicillin allergy de-labelling inpatient pathway: identifying the barriers and enablers","volume":"6","author":"Powell","year":"2024","journal-title":"JAC Antimicrob Resist"},{"key":"2025101811404575000_15.7.e096452.32","doi-asserted-by":"crossref","DOI":"10.1093\/jacamr\/dlae020","article-title":"Experiences of an inpatient penicillin allergy de-labelling pathway: capturing the patient voice","volume":"6","author":"Powell","year":"2024","journal-title":"JAC Antimicrob Resist"},{"key":"2025101811404575000_15.7.e096452.33","unstructured":"University of Exeter\u2019s Health Professions Education & Wellbeing Research Group, Available: https:\/\/medicine.exeter.ac.uk\/health-community\/research\/healthprofessions\/whoweare\/"},{"key":"2025101811404575000_15.7.e096452.34","doi-asserted-by":"crossref","DOI":"10.1186\/s13012-021-01181-5","article-title":"Conceptualizing outcomes for use with the Consolidated Framework for Implementation Research (CFIR): the CFIR Outcomes Addendum","volume":"17","author":"Damschroder","year":"2022","journal-title":"Implement Sci"},{"key":"2025101811404575000_15.7.e096452.35","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.pmedr.2017.04.002","article-title":"Development and application of the RE-AIM QuEST mixed methods framework for program evaluation","volume":"6","author":"Forman","year":"2017","journal-title":"Prev Med Rep"},{"key":"2025101811404575000_15.7.e096452.36","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2019.00064","article-title":"RE-AIM Planning and Evaluation Framework: Adapting to New Science and Practice With a 20-Year Review","volume":"7","author":"Glasgow","year":"2019","journal-title":"Front Public Health"},{"key":"2025101811404575000_15.7.e096452.37","doi-asserted-by":"publisher","DOI":"10.1007\/s10488-010-0319-7"},{"key":"2025101811404575000_15.7.e096452.38","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.jhin.2023.07.024","article-title":"Qualitative analysis of healthcare provider perspectives to evaluating beta-lactam allergies","volume":"141","author":"Gray","year":"2023","journal-title":"J Hosp Infect"},{"key":"2025101811404575000_15.7.e096452.39","doi-asserted-by":"crossref","DOI":"10.4212\/cjhp.3490","article-title":"Barriers to and Facilitators of Delabelling of Antimicrobial Allergies: A Qualitative Meta-synthesis","volume":"77","author":"Mann","year":"2024","journal-title":"Can J Hosp Pharm"},{"key":"2025101811404575000_15.7.e096452.40","doi-asserted-by":"crossref","DOI":"10.1186\/s13012-018-0726-9","article-title":"Hospital-based interventions: a systematic review of staff-reported barriers and facilitators to implementation processes","volume":"13","author":"Geerligs","year":"2018","journal-title":"Implement Sci"},{"key":"2025101811404575000_15.7.e096452.41","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.jaip.2017.02.019","article-title":"Addressing Inpatient Beta-Lactam Allergies: A Multihospital Implementation","volume":"5","author":"Blumenthal","year":"2017","journal-title":"J Allergy Clin Immunol Pract"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2024-096452","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T18:40:56Z","timestamp":1760812856000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2024-096452"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":41,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2025,7,30]]},"published-print":{"date-parts":[[2025,7]]}},"alternative-id":["10.1136\/bmjopen-2024-096452"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2024-096452","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7]]}}}